Approval · Notice of Compliance 9816 · 2008
HP-PAC: Notice of Compliance 9816
Issued October 9, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9816
- Date
- October 9, 2008
- Company
- Takeda Pharmaceuticals America IncCambridge, Massachusetts, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Helicobacter pylori eradication therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HP-PAC | 02238525 | Cancelled Post Market |
Medicinal ingredients
- LANSOPRAZOLE 30 MG per CAP
- CLARITHROMYCIN 500 MG per TAB
- AMOXICILLIN 500 MG per CAP